CVA Family Office’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151K Buy
511
+99
+24% +$27.6K 0.02% 372
2025
Q4
$79.7K Sell
412
-12
-3% -$2.06K 0.01% 466
2025
Q3
$58.4K Buy
424
+95
+29% +$10.4K 0.01% 525
2025
Q2
$29.6K Sell
329
-27
-8% -$2.16K ﹤0.01% 628
2025
Q1
$29.4K Sell
356
-10
-3% -$1.12K ﹤0.01% 620
2024
Q4
$46.1K Sell
366
-9
-2% -$1.06K 0.01% 534
2024
Q3
$50.2K Buy
375
+40
+12% +$5.39K 0.01% 510
2024
Q2
$49.7K Buy
335
+31
+10% +$3.94K 0.01% 500
2024
Q1
$34.3K Hold
304
0.01% 552
2023
Q4
$33K Buy
+304
New +$28.8K 0.01% 542
2023
Q3
Sell
-379
Closed -$42.2K 866
2023
Q2
$42.2K Buy
379
+55
+17% +$5.51K 0.01% 488
2023
Q1
$34.8K Buy
324
+5
+2% +$511 0.01% 499
2022
Q4
$27.9K Sell
319
-300
-48% -$25.7K 0.01% 510
2022
Q3
$47K Buy
619
+330
+114% +$30.1K 0.01% 386
2022
Q2
$26K Sell
289
-145
-33% -$15.1K 0.01% 493
2022
Q1
$51K Sell
434
-65
-13% -$8.23K 0.01% 395
2021
Q4
$82K Buy
+499
New +$70.2K 0.02% 276
2021
Q3
Sell
-604
Closed -$81K 828
2021
Q2
$81K Buy
604
+385
+176% +$49.3K 0.02% 275
2021
Q1
$27K Buy
+219
New +$27.5K 0.01% 356

Other funds holding TER

CVA Family Office's TER Position: Q1 2026 in Review

CVA Family Office increased its Teradyne (TER) stake by 24% in Q1 2026, buying an estimated $27.6K and bringing the position to 511 shares worth $151K. The position accounts for 0.02% of the portfolio, ranked #372.

CVA Family Office first reported a position in TER in Q1 2021 and has held it in 19 quarters since. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • CVA Family Office held 511 shares of Teradyne worth $151K as of Q1 2026.
  • CVA Family Office bought 99 Teradyne shares in Q1 2026, an estimated $27.6K.
  • Teradyne made up 0.02% of CVA Family Office's portfolio in Q1 2026, its #372 holding.
  • CVA Family Office first reported a position in Teradyne in Q1 2021 and has held it in 19 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.